TITLE

life sciences In Brief

PUB. DATE
March 2005
SOURCE
Chemical Market Reporter;3/21/2005, Vol. 267 Issue 12, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article presents information on recent developments related to life sciences. Astralis Ltd. says that preliminary results from a Phase II study of its product candidate, a novel immuno-stimulatory product for psoriasis, did not meet its primary endpoint. Generex Biotechnology Corp. reports that its product Oral-Iyn successfully replaced rapid-acting insulin in type I diabetes patients in a recently completed Phase IIb clinical study. Oral-Iyn is an oral-spray delivery system incorporating insulin.
ACCESSION #
16505647

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics